Mitochondria and autoimmunity in primary biliary cirrhosis

Area of Science:

• Immunology
• Hepatology
• Autoimmune Diseases

Background:

• Primary biliary cirrhosis (PBC) is an autoimmune liver disease primarily affecting women.
• PBC is characterized by antimitochondrial antibodies (AMAs) and specific destruction of small bile ducts.
• Patients exhibit high-titer AMAs and targeted liver-specific CD4 and CD8 T cells against mitochondrial autoantigens.

Purpose of the Study:

• To investigate the specific autoimmune mechanisms underlying primary biliary cirrhosis.
• To identify the autoantigens targeted in PBC and understand the specificity of the immune response.
• To elucidate the reasons for selective biliary cell destruction in PBC.

Main Methods:

• Analysis of autoantibodies and T-cell responses in PBC patients.
• Identification of mitochondrial autoantigens, focusing on the 2-oxo dehydrogenase complex family.
• Epitope mapping of autoantigens recognized by antibodies and T cells.
• Investigation of factors contributing to biliary cell specificity, including mucosal immunity and apoptosis.

Main Results:

• Mitochondrial autoantigens in PBC are primarily components of the 2-oxo dehydrogenase complex, with pyruvate dehydrogenase complex-E2 being a major target.
• CD4 T cells, CD8 T cells, and autoantibodies recognize epitopes within the same region, the lipoyl domain of pyruvate dehydrogenase complex-E2.
• Despite mitochondria being ubiquitous, the autoimmune attack selectively targets biliary cells.

Conclusions:

• The autoimmune response in PBC is highly specific, targeting shared epitopes on mitochondrial proteins.
• Biliary cell destruction is likely mediated by a directed mucosal immune response involving polymeric immunoglobulin receptor and IgA.
• Unique apoptotic characteristics of biliary epithelium may contribute to their selective susceptibility in PBC.